Pink semen in a patient with diabetes mellitus an uncommon effect of a common drug: A case report
摘要
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have gained significant popularity due to their proven efficacy in controlling blood glucose levels, as well as additional cardiovascular and renal benefits. Despite their therapeutic efficacy, sodium-glucose cotransporter 2 (SGLT2) inhibitors have been associated with various adverse effects. We investigated the diabetes patient who discharges pink colour semen.
Case presentationA 47-year-old obese man with uncontrolled diabetes and a history of systemic hypertension, dyslipidemia, and hypothyroidism discharges pink semen while on treatment with empagliflozin. Urine culture, semen analysis, and CT scan of the abdomen and pelvis were performed. The urine culture result showed Klebsiella count > 100,000 IU/ml. The semen analysis revealed the colonization of Serratia marcescens. Imaging studies revealed an ectopic kidney but no abnormalities in the reproductive organs.
ConclusionThe sustained glycosuria with the use of empagliflozin provides a favourable environment for Serratia marcescens growth and proliferation. Pink semen discharge is due to the colonization of Serratia marcescens. In such patients, early detection and intervention are recommended to avoid serious infections.